Summary
Direct evidence from pathologic-anatomical studies in victims of sudden cardiac death has been given for acute ischemia (caused by either an acute thrombus, plaque fissuring or an organizing thrombus) to play a major role in the genesis of sudden cardiac death. Furthermore, indirect data on the effects of drugs in the netting of acute myocardial infarction have demonstrated that treating patients with beta-blocking agents is more beneficial than treating them with a pure antiarrhythmic drug such as lidocaine. Whereas lidocaine, which also reduces the incidence of ventricular fibrillation in the setting of acute myocardial infarction, may produce an excess of mortality, beta-blockers reduce ventricular fibrillation and are associated with a prolonged survival. Further, indirect evidence on the role of ischemia in ventricular arrhythmias is given in patients with chronic ischemic heart disease by several studies on coronary revascularization and by studies on antiarrhythmic drugs versus betablockers in the same situation. In conclusion, there is clear evidence from studies of coronary revascularization and from studies on drug intervention in different patient populations with ischemic heart disease at risk for ventricular arrhythmias and/or for sudden cardiac death that ischemia play an important role in the genesis of these arrhythmias.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antman EM, Berlin JA (1992) Declining incidence of ventricular fibrillation in myocardial infarction. Circulation 86: 764–773
Baba N, Bashe WJ Jr, Keller MD et al. (1975) Pathology of atherosclerotic heart disease in sudden death. I. Organizing thrombus and acute coronary vessel lesions. Circulation 52 (Suppl 3): 53
Baker IA, Collins JV, Evans TR (1971) Prophylaxis of ventricular dysrhythimas following acute myocardial infarction: A double-blind trial of continuous intravenous infusion of lignocaine. Guys Hosp Rep 120: 1–7
Baroldi G, Falzi G, Mariani F (1979) Sudden coronary death: A post-mortem study in 208 selected cases compared to 97 “control” subjects. Am Heart J 98: 20
Baroldi G, Falzi A, Mariani F, Baroldi LA (1980) Morphology, frequency, and significance of intramural arterial lesions in sudden coronary death. G Ital Cardiol 10: 644
Bennet MA, Wilner JM, Pentecost BL (1970) Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet 2: 909–911
Chopra MP, Thadani U, Portal RW et al. (1971) Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: A double-blind trial. Br Med J 3: 687–670
Darby S, Bennett MA, Cruickshank JC et al. (1972) Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet 1: 817–819
Davies MJ, Thomas A (1984) Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 310: 1137
Dunn HM, McComb JM, Kinney CD et al. (1985) Prophylactic lidocaine in the early phase of suspected myocardial infarction. Am Heart J 100: 353–362
Guth BD, Hensch G, Seitelberger R, Ross JR (1987) Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic stenosis. Circulation 7: 661–669
Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE (1991) An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 68: 1025–1031
Hammermeister KE, DeRouen TA, Murray JA, Dodge HT (1977) Effect of aortocoronary saphenous vein bypass grafting on death and sudden death: comparison of nonrandomized medically and surgically treated cohorts with comparable coronary disease and left ventricular function. Am J Cardiol 39: 925
Holmes DR, Davis KB, Mock MB, Fisher LD, Gersh BJ, Killip Th, Pettinger M et al. (1986) The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the coronary artery surgery study. Circulation 73: 1254–1263
Horowitz LN, Spielman SR, Greenspan AM, Josephson ME (1982) Mechanisms in the genesis of recurrent ventricular tachyarrhythmias as revealed by clinical electrophysiologic studies. Ann NY Acad Sci 382: 116
ISIS-1 Collaborative Group (1986) Randomized trial of intravenous atenolol among 16,027 cases of suspected myocardial infarction. Lancet 2: 57–60
James TN (1983) Chance and sudden death. J Am Coll Cardiol 1: 164
Kent KM, Smith ER, Redwood DR, Epstein SE (1973) Electrical stability of acutely ischemic myocardium: Influences of heart rate and vagal stimulation. Circulation 67: 291–298
Koster RW, Dunning AJ (1985) Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 313: 1105–1110
Kostuk WJ, Beanlands DS (1969) Prophylactic lidocaine in acute myocardial infarction. Circulation 39 (Suppl III): 111–125.
Liberthson RR, Nagel EL, Hirschman JC et al. (1974) Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation 49: 790.
Lie KI, Wellens Hi, van Capelle KT et al. (1974) Lidocaine in the prevention of primary ventricular fibrillation: A double-blind, randomized study of 212 consecutive patients. N Engl J Med 291: 1325–1326
Lie KI, Liem KL, Louridtz WJ et al. (1978) Efficacy of lidocaine in preventing primary ventricular fibrillation with one hour after a 300 mg intramuscular injection. Am J Cardiol 42: 486–488
MacMahon ST, Collins R, Peto R, Koster RW, Yusuf S (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA 260: 1910–1916
Myerburg RJ, Conde CA, Sung RJ et al. (1980) Clinical, electrophysiologic and hemodynamic profile of patients resuscitated from prehospital cardiac arrest. Am J Med 68: 568–76
Newman WP, Tracy RE, Strong JP, et al. (1982) Pathology of sudden cardiac death. Ann NY Acad Sci 382: 39
O’Brien KP, Taylor PM, Croxson RS: Prophylactic lignocaine in hospitalized patients with acute myocardial infarction. Med J Aust Suppl 2: 36–37
Pitt A, Lipp H, Anderson ST (1971) Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet 1: 612–616
Reeves TJ (1985) Relation and interdependence of angina pectoris and sudden death in persons with coronary atherosclerotic heart disease. J Am Coll Cardiol 5: 167B - 74B
Ryden L, Arciniego R, Arnonan K (1983) A double-blind trial of metoprolol in acute myocardial infarction: Effect on ventricular tachyarrhythmias. N Engl J Med 308: 614–618
Sandler G, Dey N, Amonkar J (1976) Prophylactic intramuscular lidocaine in myocardial infarction. Curr Ther Res 20: 563–573
Siebels J, Cappato R, Riippel R, Schneider MAE, Kuck KH and the CASH investigators (1993) ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg. PACE Pacing Clin Electrophysiol 16: 552–558
Singh JB, Kocot SL (1976) A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction. Am Heart J 91: 430–436
Singh BN (1989) Advantages of beta-blockers versus anti-arrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Am J Cardiol 66: 9C - 20C
Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, v-Leitner ER (1992) A comparison of electrophysiologically guided antiarrhythmic drug therapy with betablocker therapy in patients with symptomatic sustained ventricular tachyarrhythmias. New Engl J Med 327: 987–92
Tresch DD, Keelan MH jr, Siegel R, Troup PJ, Bonchek LI, Olinger GN, Brooks HL (1984) Long-term survival after prehospital sudden cardiac death. Am Heart J 108 1: 1984
Vismara LA, Miller RR, Price JE, Karem R, DeMaria AN, Mason DT (1977) Improved longevity due to reduction in sudden death by aorto-coronary bypass in coronary atherosclerosis: prospective evaluation of medical versus surgical therapy in matched patients with multivessel disease. Am J Cardiol 39; 919
Warnes CA, Roberts WC (1984) Sudden coronary death: Relation of amount and distribution of coronary narrowing at necropsy to previous symptoms of myocardial ischemia, left ventricular scarring, and heart weight. Am J Cardiol 54: 65
Wyse DG, Kellen J, Rademaker AW (1988) Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction. J Am Coll Cardiol 12: 507–513
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt
About this chapter
Cite this chapter
Kuck, KH., Siebels, J., Schneider, M.A.E. (1994). Therapeutic consequences of newer studies addressing the problem of myocardial ischemia and ventricular arrhythmias. In: Zehender, M., Meinertz, T., Just, H. (eds) Myocardial Ischemia and Arrhythmia. Steinkopff. https://doi.org/10.1007/978-3-642-72505-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-72505-0_20
Publisher Name: Steinkopff
Print ISBN: 978-3-642-72507-4
Online ISBN: 978-3-642-72505-0
eBook Packages: Springer Book Archive